Debate: Is LAA occlusion an alternative to oral anticoagulation in low bleeding risk patients? Antagonist:LAA occlusion should be considered for (N)OAC in-tolerant patients primarily. NOT for everyone!
New clinical data for left atrial appendage occlusion therapy, presented & published in 2016. Includes a critical review of the Stroke Prevention section in the 2016 ESC Atrial Fibrillation guidelines.
Why might LAA occlusion therapy be cost effective, despite a high procedural cost? This presentation is an overview of the health economics data available for left atrial appendage closure therapy.
Review of new left atrial appendage occlusion devices that came to market (CE-mark) or underwent a major redesign in 2016.
Here you will find the a selected series of talks and performances focused on left atrial appendage occlusion. They are seleced from conferences, events -- and the best of the web. More than 20 talks are now avialable.
Find a comprehensive overview of relevant information about left atrial appendage occlusion and stroke prevention and related societies and industry.
The Atrial Fibrillation Association (AFA) is a UK registered charity which focuses on raising awareness of Atrial Fibrillation (AF) by providing information and support materials for patients and medical professionals involved in detecting, diagnosing and managing Atrial Fibrillation.
